Namibian private equity firm Eos Capital, through its Allegrow Fund, has successfully completed the exit of its investment in Erongo Medical Group (EMG).
Over the past ten years, Eos Capital has established itself as a cornerstone of Namibia’s private equity landscape, successfully raising and deploying capital through its three flagship funds:
- Allegrow Fund
- Euphrates Fund
- Namibia Infrastructure Development and Investment Fund (NIDF 1)
As the firm enters its second decade, it is positioning itself for renewal, innovation, and regional expansion.
The investment in EMG was originally made as part of Eos Capital’s broader strategy to gain exposure to defensive, high-impact sectors within Namibia, with a particular emphasis on healthcare infrastructure and specialized medical services. This approach aimed to support essential industries that deliver long-term value and resilience, while contributing to the country’s socio-economic development.
This transaction marks a significant milestone for Eos Capital, representing the firm’s first realized exit since its inception. It underscores the effectiveness of its investment philosophy and operational execution.
Commenting on the achievement, Elzine Mushambi, Managing Director of Eos Capital, stated:
The successful exit of our investment in EMG is a direct result of our focused strategy and active stewardship. It demonstrates our commitment to identifying resilient assets, driving value creation, and ultimately returning capital to our investors. This exit is a testament to the quality of our portfolio, the execution capability of our team, and a significant win for the Namibian private equity landscape.
